India’s Windlas Biotech files DRHP to raise funds via IPO 2021-05-14T19:42:59-04:00May 14th, 2021| share this article! The IPO consist of a fresh issue of Rs 165 crore and an offer for sale of up to 5.14 million shares by its current promoters, shareholders. Read More share this article! Related Posts Australian wine returns to China, but ‘good old days’ gone and adversity remains May 4th, 2024 Poster child or cautionary tale? Should China copy success of its ex-backwater? May 3rd, 2024 Geely’s Zeekr seeks up to $5.13bn valuation in U.S. IPO May 3rd, 2024 China’s Zeekr plans to raise up to $368m in U.S. IPO May 3rd, 2024
